PD-1 regulates CD4<sup>+</sup> T cell-mediated CD8<sup>+</sup> T cell responses in the brain to balance viral control and neuroinflammation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42744829.
- Also identified by DOI 10.1038/s41467-026-76762-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Programmed cell death protein 1 (PD-1) is expressed by T cells during progressive multifocal leukoencephalopathy (PML), a life-threatening brain disease caused by the human-only JC polyomavirus (JCPyV). PD-1 checkpoint immunotherapy has benefited some PML patients, but reasons for its variable outcomes are unclear. Using mouse polyomavirus (MuPyV), we show that PD-1 loss acts in a brain-autonomous manner to increase the magnitude of brain-infiltrating CD4<sup>+</sup> and CD8<sup>+</sup> T cells and the function of virus-specific CD8<sup>+</sup> T cells; in concert, brain virus levels decline and neuroinflammation increases. Deletion of PD-1 in CD4<sup>+</sup> T cells, but not CD8<sup>+</sup> T cells, recapitulates effects of global PD-1 loss. Single-cell RNA sequencing shows that PD-1-deficient CD8<sup>+</sup> T cells cluster as effectors while transcripts associated with proliferation and function are upregulated with loss of PD-1. Thus, CD4<sup>+</sup> T cell-intrinsic PD-1 signaling balances antiviral defense against neural injury during polyomavirus infection of the brain.
Medical subject headings
- Programmed Cell Death 1 Receptor
- CD8-Positive T-Lymphocytes
- CD4-Positive T-Lymphocytes
- Brain
- Leukoencephalopathy, Progressive Multifocal
- Neuroinflammatory Diseases